6-month cardiac follow-up data finally arrives

In August 2021, the JCVI said they wanted to delay a decision about children’s covid vaccines until 6-month followup data was available on children from the US who had sustained vaccine-induced myocarditis. But instead of waiting, they passed the decision to the Chief Medical Officers, who decided the jabs would be good for children’s mental health! Well the data is now in and it is not encouraging.

Read More

Does mother know best?

The cost-benefit decisions that drive NHS spending can be hard to reconcile. On one hand, loving parents face roadblocks from courts and medical experts when seeking life-saving treatments for their children. On the other, vast sums are spent on COVID-19 interventions, raising the question: What is a life truly worth, and who gets to decide? Shouldn’t loving parents have more say when the stakes are so high?

Read More

Why do Monkeypox mRNA vaccines cause the same problems as Covid vaccines?

Here we reproduce a letter written to an MP by a constituent.

The letter raises concerns about the potential risks of approving future mRNA vaccines under a “platform authorisation” model whereby updates are assumed to be safe because the underlying methodology is considered safe – the way seasonal egg based influenza vaccines were regulated. This means the Monkeypox mRNA vaccines and others need not be authorised on a product-specific basis as discussed in a May 2024 MHRA Board meeting, but can piggy back on the claims made about the safety of covid vaccines. What could possibly go wrong?

Read More

AstraZeneca product withdrawn

At the end of April AstraZeneca admitted in court that its product could cause clots that could kill. A proportion of the claimants who were vaccinated after the 7th April were asked by the legal team to withdraw from the case because at that point AstraZeneca added a line into their patient information leaflet to include a rare risk of clots as an adverse event.

Read More